AstraZeneca (AZ) and Merck – known as MSD outside the US and Canada – have shared positive results from a late-stage study of ...

Novavax has announced that the US Food and Drug Administration (FDA) has lifted its clinical hold on a late-stage study of ...

Johnson & Johnson (J&J) has announced that its anti-FcRn antibody nipocalimab has become the first investigational therapy to ...

The National Institute for Health and Care Excellence (NICE) has recommended Blueprint Medicines’ Ayvakyt (avapritinib) to treat patients with the rare blood disorder systemic mastocytosis (SM). The ...

A UK study has demonstrated that interventions to reduce respiratory syncytial virus (RSV) infections could help to reduce antibiotic prescribing and therefore antimicrobial resistance (AMR), which is ...

Novo Nordisk and Ascendis Pharma have partnered to develop therapies for metabolic and cardiovascular diseases, including a once-monthly GLP-1 receptor agonist that will initially target type 2 ...

Medscape Education is committed to disseminating the outcomes of the education programs through peer-reviewed publications and posters at leading medical conferences around the world. To this end, ...

This handy resource ranks the top companies in the pharmaceutical industry by their global sales, as well as by revenues in the US, Europe and Japan. The Top Pharma List also features profile pages ...

Spoonful of Sugar Spoonful of Sugar (SoS) is a unique and diverse team of specialists in illness and medicines-related behaviour, hand-picked from academic, healthcare, communications, creative and ...

Rock Unlimited: Solid science. Fluid thinking. Lasting change.

In 2013 we grew by 20%. We recruited top talent, from the Sun newspaper, Yahoo! and the ABPI. We continued to expand our creative and digital studio. We won 6 industry awards and were shortlisted for ...

DANIELS HUDSPETH is a new kind of healthcare brand consultancy: one that recognises that yesterday’s marketing models are no longer applicable. Today’s challenging marketing realities mean that ...